Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (104)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pedersen, S. S.
Right arrow Articles by Rosendal, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedersen, S. S.
Right arrow Articles by Rosendal, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1986) 17, 505-516
© 1986 The British Society for Antimicrobial Chemotherapy


research-article

An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre

Svend Stenvang Pedersen*, Christian Koch*, Niels Heiby{dagger} and Kirsten Rosendal{ddagger}

*Paediatric Department G Rigshospitalet {dagger}Statens Seruminstitut, Department of Clinical Microbiology Rigshospitalet {ddagger}Department of Hospital Infection Copenhagen, Denmark

accepted 21 November 1985


Early in 1983 an epidemic of a Pseudomonas aeruginosa resistant to aminoglycosides, carbenicillin, ureidopenicillins, ceflazidime, oefsulodin and imipenem occurred in a cystic fibrosis centre. Most of the epidemic could be attributed to a specific nosocomial strain by means of O-grouping and phage-typing. This strain was present in the centre at a low frequency in 1973 and developed resistance during courses of chemotherapy. The epidemic was stopped by isolating patients with the resistant strains. Restrictive and selective use of antibiotics have not been sufficient to eradicate the resistant strains, which persist in 42% of the patients. The extensive use of the third generation cephalosporins in the clinic is probably responsible for inducing and selecting for the resistant strains. Clustering of patients in the centre has facilitated the spread. First-line use of older ß-lactam antibiotics, close bacteriological monitoring and prompt isolation of patients with resistant strains are recommended.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
M. E. Skindersoe, M. Alhede, R. Phipps, L. Yang, P. O. Jensen, T. B. Rasmussen, T. Bjarnsholt, T. Tolker-Nielsen, N. Hoiby, and M. Givskov
Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa
Antimicrob. Agents Chemother., October 1, 2008; 52(10): 3648 - 3663.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Jelsbak, H. K. Johansen, A.-L. Frost, R. Thogersen, L. E. Thomsen, O. Ciofu, L. Yang, J. A. J. Haagensen, N. Hoiby, and S. Molin
Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients
Infect. Immun., May 1, 2007; 75(5): 2214 - 2224.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Van daele, M. Vaneechoutte, K. De Boeck, C. Knoop, A. Malfroot, P. Lebecque, J. Leclercq-Foucart, L. Van Schil, K. Desager, and F. De Baets
Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients
Eur. Respir. J., October 1, 2006; 28(4): 740 - 747.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
B. Lee, J. A. J. Haagensen, O. Ciofu, J. B. Andersen, N. Hoiby, and S. Molin
Heterogeneity of Biofilms Formed by Nonmucoid Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis
J. Clin. Microbiol., October 1, 2005; 43(10): 5247 - 5255.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
D. Peckham
Introduction
Chronic Respiratory Disease, October 1, 2004; 1(4): 203 - 203.
[PDF]


Home page
Eur Respir JHome page
M.R. O'Carroll, M.W. Syrmis, C.E. Wainwright, R.M. Greer, P. Mitchell, C. Coulter, T.P. Sloots, M.D. Nissen, and S.C. Bell
Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units
Eur. Respir. J., July 1, 2004; 24(1): 101 - 106.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
N. Bagge, M. Hentzer, J. B. Andersen, O. Ciofu, M. Givskov, and N. Hoiby
Dynamics and Spatial Distribution of {beta}-Lactamase Expression in Pseudomonas aeruginosa Biofilms
Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1168 - 1174.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
L. Saiman and J. Siegel
Infection Control in Cystic Fibrosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 57 - 71.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. L. Gibson, J. L. Burns, and B. W. Ramsey
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.M. Jones, L. Martin, R.J. Bright-Thomas, M.E. Dodd, A McDowell, K.L. Moffitt, J.S. Elborn, and A.K. Webb
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Eur. Respir. J., September 1, 2003; 22(3): 503 - 506.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
A.J. CANT, S.B. GORDON, R.C. READ, C.A. HART, and C. WINSTANLEY
Respiratory infections: Proceedings of the Eighth Liverpool Tropical School Bayer Symposium of Microbial Disease held on 3 February 2001
J. Med. Microbiol., November 1, 2002; 51(11): 903 - 914.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. S. Armstrong, G. M. Nixon, R. Carzino, A. Bigham, J. B. Carlin, R. M. Robins-Browne, and K. Grimwood
Detection of a Widespread Clone of Pseudomonas aeruginosa in a Pediatric Cystic Fibrosis Clinic
Am. J. Respir. Crit. Care Med., October 1, 2002; 166(7): 983 - 987.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. P. Speert, M. E. Campbell, D. A. Henry, R. Milner, F. Taha, A. Gravelle, A. G. F. Davidson, L. T. K. Wong, and E. Mahenthiralingam
Epidemiology of Pseudomonas aeruginosa in Cystic Fibrosis in British Columbia, Canada
Am. J. Respir. Crit. Care Med., October 1, 2002; 166(7): 988 - 993.
[Abstract] [Full Text]


Home page
Clin. Microbiol. Rev.Home page
J. B. Lyczak, C. L. Cannon, and G. B. Pier
Lung Infections Associated with Cystic Fibrosis
Clin. Microbiol. Rev., April 1, 2002; 15(2): 194 - 222.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P. G. Ambrose, R. C. Owens Jr, M. J. Garvey, and R. N. Jones
Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime
J. Antimicrob. Chemother., March 1, 2002; 49(3): 445 - 453.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
C A. Hart and C. Winstanley
Persistent and aggressive bacteria in the lungs of cystic fibrosis children
Br. Med. Bull., March 1, 2002; 61(1): 81 - 96.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. J. Dancer
The problem with cephalosporins
J. Antimicrob. Chemother., October 1, 2001; 48(4): 463 - 478.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
O. Ciofu, V. Fussing, N. Bagge, C. Koch, and N. Hoiby
Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, {beta}-lactamase activity and RiboPrinting
J. Antimicrob. Chemother., September 1, 2001; 48(3): 391 - 396.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
L. V. F. DA SILVA FILHO, J. E. LEVI, C. N. O. BENTO, J. C. RODRIGUES, and S. R. T. DA SILVA RAMOS
Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic
J. Med. Microbiol., March 1, 2001; 50(3): 261 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. Campbell, E. Mahenthiralingam, and D. P. Speert
Evaluation of Random Amplified Polymorphic DNA Typing of Pseudomonas aeruginosa
J. Clin. Microbiol., December 1, 2000; 38(12): 4614 - 4615.
[Abstract] [Full Text]


Home page
ThoraxHome page
J S Elborn, R J Prescott, B H R Stack, M C Goodchild, J Bates, C Pantin, N Ali, D J Shale, and M Crane
Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs
Thorax, May 1, 2000; 55(5): 355 - 358.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
P.-R. Hsueh, L.-J. Teng, P.-C. Yang, Y.-C. Chen, S.-W. Ho, and K.-T. Luh
Persistence of a Multidrug-Resistant Pseudomonas aeruginosa Clone in an Intensive Care Burn Unit
J. Clin. Microbiol., May 1, 1998; 36(5): 1347 - 1351.
[Abstract] [Full Text]


Home page
PediatricsHome page
P. M. Farrell, G. Shen, M. Splaingard, C. E. Colby, A. Laxova, M. R. Kosorok, M. J. Rock, and E. H. Mischler
Acquisition of Pseudomonas aeruginosa in Children With Cystic Fibrosis
Pediatrics, November 1, 1997; 100(5): e2 - e2.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.